13Indexed trials
mesh condition
Tuberous Sclerosis
Intelligence
Tuberous Sclerosis intelligence: 13 indexed trials, 2 recruiting studies, 12 sponsors across 11 countries.
2Recruiting
12Sponsors
11Countries
Leading sponsors
Jazz Pharmaceuticals21 recruiting
Beijing Children's Hospital10 recruiting
Children's Hospital Medical Center, Cincinnati10 recruiting
Erasmus Medical Center10 recruiting
Martina Bebin10 recruiting
Mustafa Sahin10 recruiting
NYU Langone Health10 recruiting
Noema Pharma AG10 recruiting
Peking Union Medical College Hospital10 recruiting
UK Kidney Association11 recruiting
Aucta Pharmaceuticals, Inc10 recruiting
University of Pennsylvania10 recruiting
Geographic activity
United States8trials
China3trials
United Kingdom3trials
Poland2trials
Italy2trials
Turkey (Türkiye)1trials
Netherlands1trials
India1trials
Israel1trials
Canada1trials
Spain1trials
Leading interventions
AED1trials
Aspirin1trials
Basimglurant with crossover to Placebo1trials
Cannabidiol Oral Solution [Epidiolex]1trials
Delayed Vigabatrin (Placebo)1trials
Early Vigabatrin1trials
Epidiolex 100 mg/mL Oral Solution1trials
Everolimus1trials
Placebo ointment1trials
Placebo with crossover to Basimglurant1trials
RAD0011trials
Sirolimus 0.2%1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.